Удосконалення лікувальної тактики ведення жінок з ендометріозом

In: 2309-4117 · 2014 · W7113611519
article OA: green CC0
🔓 Open OA copy Full text JSON View on OpenAlex
AI-generated summary by gemini-2.5-flash-lite, 2026-07-16

This study compared progestin therapy alone with combined progestin and non-hormonal therapy for endometriosis, finding slightly higher clinical efficacy with the combination.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-16 · read from full text

The paper developed and evaluated a complex drug therapy regimen for women with endometriosis, focusing on an 80-woman cohort with adenomyosis followed over 6 months and divided into two treatment groups. One group received dienogest (Vissane) 2 mg daily for 6 months, while the other received dienogest 2 mg daily for 6 months plus Adaptol (mebicar 500 mg) twice daily and Noophen (phenibutum 250 mg) twice daily for three months. The authors report slightly higher clinical efficacy with the combination of progestogen therapy and the non-hormonal drugs, with clinical outcomes tracked using an “integral indicator of pathology.” This paper is centrally about endometriosis — it compares dienogest-based progestin therapy versus dienogest plus mebicar and phenibut in women with adenomyosis in the context of endometriosis management.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

It was developed and tested a complex drug therapy of women with endometriosis. Within 6 months of the study’s authors are actively watching the 80 women with adenomyosis, which were divided into two groups. The first group of women (n = 42) administered progestin therapy for 6 months – Vissane (dienogest 2 mg). The second group included 38 patients treated with combined therapy: Vissane (dienogest 2 mg) daily for 6 months, Adaptol (mebicar 500 mg) twice a day and Noophen (phenibutum 250 mg) twice a day for three months.The results showed a slightly higher clinical efficacy of progestogen therapy (Visan) in combination with non-hormonal drugs (Adptol and Noophen).
Full text 3,515 characters · extracted from oa-html · click to expand
Improved therapeutic management of women with endometriosis DOI: https://doi.org/10.18370/2309-4117.2014.18.24-27Keywords: endometriosis, adenomyosis, integral indicator of pathology, Vissane, Adaptol, NoophenAbstract It was developed and tested a complex drug therapy of women with endometriosis. Within 6 months of the study’s authors are actively watching the 80 women with adenomyosis, which were divided into two groups. The first group of women (n = 42) administered progestin therapy for 6 months – Vissane (dienogest 2 mg). The second group included 38 patients treated with combined therapy: Vissane (dienogest 2 mg) daily for 6 months, Adaptol (mebicar 500 mg) twice a day and Noophen (phenibutum 250 mg) twice a day for three months. The results showed a slightly higher clinical efficacy of progestogen therapy (Visan) in combination with non-hormonal drugs (Adptol and Noophen). References - Mashkovskiy M.D. «The medicaments.» Moscow, 1(1993):138. - Babichev V.N. «Neurohormonal regulation of ovarian cycle.» M.: Medical (1984):238. - Al-Jefout M., Dezarnaulds G., Cooper M., Tokushige N. et al. «Diagnosis of endometriosis by detection of nerve fibres in an endometrial biopsy: a double blind study.» Hum Reprod, 24(12)(2009):3019-3024. - Okada H. et al. «The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro.» Mol Hum Reprod,4(7)(2001):341-347. - Sasagawa S., Shimizu Y., Kami H. et al. «Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile.» Steroids, 73(2008): 222-23. - Shimizu Y. et al. «Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression.» Mol Hum Reprod,10(15)(2009):693-701. - Tatsum H.i., Kitawaki J.i., Tanaka K.i., Hosoda T., Honjo H. «Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule – 1 and vascular cell adhesion molecule – 1 by endothelial cell as compared with other sytetic progestins.» Maturitas, 42(2002):287-94. - Burlaka O.V., Stebljuk V.V. «Assessment of quality of life as a criterion for the effectiveness of treatment and rehabilitation interventions at reproductive disorders.» Journal of Physiotherapy and Health Resort, 18(1)(2012):75-79. - Shchukina N.A., Buyanova, S.N. «The modern view on the diagnosis and treatment of endometriosis». GBUZ «Moscow Regional Research Institute of Obstetrics and Gynecology,» Ministry of Health, BC. Russian Medical Journal, 14 (2014). Downloads Published How to Cite Issue Section License Copyright (c) 2014 Т. Ф Татарчук, Н. Ф. Захаренко, І. П. Маноляк, В. П. Ковбасій This work is licensed under a Creative Commons Attribution 4.0 International License. Authors who publish with this journal agree to the following terms: - Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. - Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisadenomyosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK